chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: F
Vaccine: MNQ
Symptoms: Drug administration error
Clinical narrative: Initial report received from a health care professional (nurse) on 02 Dec 2010: This patient was vaccinated with only the MenCWY liquid conjugate component of MENVEO (batch number: 100001) intramuscularly without being reconstituted with the MenA conjugate component. No adverse events were noted following this medication error. The patient was scheduled for re-vaccination, however she had not received it yet.
Sex: U
Vaccine: MNQ
Symptoms: Drug administration error
Clinical narrative: Initial report received from health care professional on 09 Dec 2010: This patient was vaccinated with only the MenCWY liquid conjugate component of MENVEO (batch number: not known), intramuscularly without being reconstituted with the MenA conjugate component. One patient out of 4 patients received had this drug administration error but the reporter was unable to determine which patient received partial dose of MENVEO.
Age: 28.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Drug administration error, No adverse event
Clinical narrative: Initial report received from a health care professional on 13 Dec 2010: This patient was vaccinated with MENVEO (batch number unknown) intramuscularly on an unspecified date. The patient received only MenCWY liquid conjugate component of MENVEO. No adverse event was reported. Follow up report received from health care professional on 03 Jan 2011: The patient had medical history of brain surgery. The patient received MENVEO (batch number: 090601A) intramuscularly on 22 Nov 2010 morning. The patient also received Tdap on the same day intramuscularly.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Initial report received from a health care professional (nurse) on 16 Dec 2010: This patient was vaccinated with only the MenCWY liquid component (C, Y and w-135) of MENVEO (batch number: 022011) intramuscularly on an unspecified date. The outcome was reported as unknown. No other information was provided.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial physician report received on 03 Dec 2010: This patient with an unknown medical history was vaccinated with MENVEO (batch number: unknown) on 02 Sep 2010 which was stored for around 2 months at 30 F. No adverse event was reported following this incorrect storage.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial physician report received on 03 Dec 2010: This patient with an unknown medical history was vaccinated with MENVEO (batch number: unknown) on 24 Aug 2010 which was stored for about 2 months at 30 F. No adverse event was reported following this incorrect storage.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial physician report received on 03 Dec 2010: This patient with an unknown medical history was vaccinated with MENVEO (batch number: unknown) on 06 Nov 2010 which was stored for around 2 months at 30 F. No adverse event was reported following this incorrect storage.
Age: 1.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Initial report received from the health care professional on 15 Dec 2010: This patient was vaccinated intramuscularly with only MenA lyophilized conjugate component of MENVEO (batch number 024011) that was reconstituted with a sterile diluent on 15 Dec 2010. The patient did not receive the MenCWY-135 liquid conjugate component of MENVEO. No adverse reaction had occurred following this administration.
Age: 1.39
Sex: M
Vaccine: MNQ
Symptoms: Accidental exposure, No adverse event
Clinical narrative: Initial report received from a health care professional on 21 Dec 2010: This 15 months old patient was inadvertently vaccinated with 0.5 ml MENVEO (batch number: 100023), intramuscularly on 10 Nov 2010. No adverse events were noted following this medication error.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered, No adverse event
Clinical narrative: Initial report received from a nurse on 22 Dec 2010: This patient was vaccinated with MENVEO (batch number 10003) 0.5mL IM dose on 20 Dec 2010. The patient received only the MenCWY liquid conjugate component of the vaccine without being reconstituted with MenA lyophilized conjugate component. No adverse event was reported.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site pain
Clinical narrative: Initial report received from a health care professional on 29 Dec 2010: This patient was received a single dose of MENVEO (batch number: 100025) on 03 Sep 2010 and then received another dose (batch number: 100023) on 29 Dec 2010. No adverse events were reported. Follow-up report received from a health care professional on 04 Jan 2011: This patient was vaccinated with first dose of MENVEO (batch number 100025) at right arm deltoid on 03 Sep 2010 and second dose (batch number 100023) at left arm deltoid on 29 Dec 2010. On 29 Dec 2010, the patient presented site tenderness and the left deltoid achy. The event recovered on 31 Dec 2010. The events were reported as non-serious.
Age: 15.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Drug administration error, No adverse event
Clinical narrative: Initial report received from a pharmacist on 28 Dec 2010: This patient was vaccinated with MENVEO (batch number: unknown) on an unknown date. The patient was administered with MenCWY component only, without MenA conjugate component. Combined follow-up report received on 25 Jan 2011 and 31 Jan 2011: The batch number was reported as 100022. The patient was vaccinated with MENVEO on 21 Dec 2010. The patient was also on some concomitants. No known side effects occurred due to usage of wrong diluents.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Initial report received from a physician on 29 Dec 2010: This patient was vaccinated with reconstituted MENVEO (batch number 100022) 0.5 ml intramuscularly on 09 Dec 2010. Immediately after vaccination, he experienced redness, swelling and pain at the injection site which lasted four days. The outcome of the events was recovery as of 13 Dec 2010.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Initial physician report received on 29 Dec 2010: The patient received MENVEO (batch number 10022), 0.5 ml, intramuscularly, on 14 Dec 2010. The patient experienced redness, swelling and pain at injection site, on 14 Dec 2010. The outcome of event was completely recovered on 16 Dec 2010. Follow-up report received from physician on 10 Jan 2011: Patient demographic updated. This patient received MENVEO (batch number 100022) 0.5 ml in left deltoid on 14 Dec 2010.
Sex: U
Vaccine: MNQ
Symptoms: Incorrect storage of drug
Clinical narrative: Initial report received from a physician on 03 Jan 2011: This patient was vaccinated with MENVEO (batch number unknown) which had been exposed at -3 degree Celsius temperature for 24 hours on an unspecified date. It was unknown that adverse reaction had occurred following this administration of vaccine.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Drug administration error, No adverse event
Clinical narrative: Initial report received from a pharmacist on 11 Jan 2011: This patient was vaccinated with MENVEO (batch number unknown) on an unspecified date. The patient received 0.5 mL IM dose only the MenCWY liquid conjugate component without mixing with MenA conjugate component. No adverse event occurred due to medication error.
Age: 22.0
Sex: F
Vaccine: MNQ
Symptoms: Drug administration error
Clinical narrative: Initial health care professional (medical assistant) report received on 28 Jan 2011: This patient with an unknown medical history was vaccinated with MENVEO (batch number: 090601A) intramuscularly on 27 Jan 2011. But during she was administered with only Men CYW-135 component without Men A portion. The outcome was not reported.
Age: 30.0
Sex: F
Vaccine: MNQ
Symptoms: Drug administration error, No adverse event, Underdose
Clinical narrative: Initial health care professional (nurse) report received on 07 Feb 2011: This patient with an unknown medical history was vaccinated with MENVEO (batch number: 022011) intramuscularly in 07 Feb 2011. But the patient received only partial dose and the lyophilized-Men A powder, was reconstituted using saline instead of Men CYW liquid component. No adverse event was reported following this under dose and drug administration error.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Drug administration error, No adverse event
Clinical narrative: Initial report received from a health care professional on 10 Feb 2011: This patient was vaccinated with MENVEO (batch number M10030) on 08 Feb 2011. The patient received only MenCYW-135 liquid conjugate component and did not receive MenA lyophilized component of MENVEO. No adverse event had occurred.
Sex: M
Vaccine: MNQ
Symptoms: Incorrect drug dosage form administered
Clinical narrative: Initial report received from a nurse on 16 Feb 2011: This patient was vaccinated with MENVEO (batch number A100028) 0.5 ml dose, intramuscularly on 09 Feb 2011. The patient received MENVEO lyophilized powder reconstituted with saline instead of liquid conjugate component 09 Feb2011. No other information reported.
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Abdominal pain, Abdominal pain lower, Decreased appetite, Insomnia, Malaise
Clinical narrative: Following administration of Prevnar 13, child showed signs of malaise in the afternoon post-administration, did not eat or sleep well that night, and woke the next morning to a temperature of 101.9 and complaints of lower abdominal pain. Alternating doses of childrens' Tylenol and Motrin were administered throughout day two.  However, child continued to be febrile, with fever rising to 102.9, then 103, with continued and more frequent complaints of abdominal pain, lack of appetite, and disturbed sleep up to this time (approximately midnight on day two).
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Pyrexia, Sleep disorder
Clinical narrative: Following administration of Prevnar 13, child showed signs of malaise in the afternoon post-administration, did not eat or sleep well that night, and woke the next morning to a temperature of 101.9 and complaints of lower abdominal pain. Alternating doses of childrens' Tylenol and Motrin were administered throughout day two.  However, child continued to be febrile, with fever rising to 102.9, then 103, with continued and more frequent complaints of abdominal pain, lack of appetite, and disturbed sleep up to this time (approximately midnight on day two).
Age: 3.0
Sex: F
Vaccine: PNC13
Symptoms: Cough, Hyperaesthesia, Immediate post-injection reaction, Injection site erythema, Injection site pain
Clinical narrative: RED AND SWOLLEN ARM. PAINFUL TO TOUCH ARM. FEVER 102-103. IMMEDIATELY FOLLOWING IMMUNIZATION. 2 DAYS LATER FEVER STILL 102-103, SWOLLEN THROAT, CONGESTION, THROWING UP MUCUS, COUGHING, AND LARYNGITIS.  FEVER FINALLY WENT AWAY AFTER A WEEK.  SHE IS STILL CONGESTED AND COUGHING.
Age: 3.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site swelling, Laryngitis, Pharyngeal oedema, Pyrexia, Respiratory tract congestion
Clinical narrative: RED AND SWOLLEN ARM. PAINFUL TO TOUCH ARM. FEVER 102-103. IMMEDIATELY FOLLOWING IMMUNIZATION. 2 DAYS LATER FEVER STILL 102-103, SWOLLEN THROAT, CONGESTION, THROWING UP MUCUS, COUGHING, AND LARYNGITIS.  FEVER FINALLY WENT AWAY AFTER A WEEK.  SHE IS STILL CONGESTED AND COUGHING.
Age: 3.0
Sex: F
Vaccine: PNC13
Symptoms: Vomiting
Clinical narrative: RED AND SWOLLEN ARM. PAINFUL TO TOUCH ARM. FEVER 102-103. IMMEDIATELY FOLLOWING IMMUNIZATION. 2 DAYS LATER FEVER STILL 102-103, SWOLLEN THROAT, CONGESTION, THROWING UP MUCUS, COUGHING, AND LARYNGITIS.  FEVER FINALLY WENT AWAY AFTER A WEEK.  SHE IS STILL CONGESTED AND COUGHING.
Age: 1.25
Sex: M
Vaccine: PPV
Symptoms: Ear infection
Clinical narrative: Bilateral Ear Infection
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Local reaction
Clinical narrative: Localized injection site reaction - erythema w/n swelling.
Age: 38.0
Sex: M
Vaccine: TDAP
Symptoms: Injected limb mobility decreased, Joint range of motion decreased, Musculoskeletal pain
Clinical narrative: Received Tdap vaccine 4/7/11 left deltoid - c/o shoulder pain at site continues limiting range of motion shoulder - started day #2 - no fever, no redness, no swelling - no pain at rest - hard to lift arm up - referred to PCP & take Ibuprofen.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HBPV, PNC13, RV5
Symptoms: Gastrointestinal stoma complication, Ileostomy, Post procedural complication
Clinical narrative: Presented with prolapsed ileostomy, compromise of ostomy perfusion, underwent reduction of ileostomy prolapse and ostomy revision.
Age: 0.51
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Condition aggravated, Ileostomy, Intussusception, Post procedural complication, Small intestinal resection
Clinical narrative: Pt w/ prolapsed ileostomy. Went to OR and noted to have intussusscepted 18cm small bowel. 36cm had to be resected, ileostomy was revised.
Age: 10.0
Sex: F
Vaccine: FLU3
Symptoms: Dyskinesia, Eyelid function disorder, VIIth nerve paralysis
Clinical narrative: Pt presented to Peds clinic on 11/29/10 complaining that left side of face was droopy since last Wed. She could not blink her eye lids or move mouth.  Pt was diagnosed with Bell's Palsy and treated with prednisone.
Age: 28.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Hypoaesthesia facial, VIIth nerve paralysis, Vision blurred
Clinical narrative: Pt presented to ER on 1/22/11 complaining of numbness L side face and blurred vision L eye x3 days. Pt was diagnosed with Bell's Palsy and treated with lacrilube eye ointment only.
Age: 21.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Feeling abnormal, Loss of consciousness
Clinical narrative: Approx 20 sec after receiving Gardasil vacc patient stated felt funny, slumped over and passed out.
Age: 0.18
Sex: M
Vaccine: DTAP
Symptoms: Abnormal faeces, Lethargy, Mucous stools, Screaming, Vomiting
Clinical narrative: Extreme lethargic reaction for a period of four days and nights. Uncontrollable screaming for two days and nights upon being awoken for feedings. Throwing up following every feeding for a period of a month following vaccine. Abnormal stools filled with mucus and a pungent unusual odor.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling
Clinical narrative: Patient reports an egg size swelling around site of injection around 12 noon and swelling increased by evening. Pt visits Emergency Centre. Per pt she was given prednisone injection. Reported today swelling decreased.
Age: 65.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Administered ZOSTAVAX 4/13/11 - called pt to check 4/14/11. Came to pharmacy 4/17/11 at 2:20 pm. Area of injection red, swollen, warm & moving down towards elbow. Merck closed. RPh on duty will call Merck.
Age: 65.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Pain
Clinical narrative: Administered ZOSTAVAX 4/13/11 - called pt to check 4/14/11. Came to pharmacy 4/17/11 at 2:20 pm. Area of injection red, swollen, warm & moving down towards elbow. Merck closed. RPh on duty will call Merck.
Age: 1.29
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Crying, Feeling abnormal, Insomnia, Pruritus, Pyrexia
Clinical narrative: Son had a fever from 4/14 to 4/16, along with a rash forming on both vaccination sites on thigh. Afterwards forming small rash and bumps all over body from head to bottom of his feet and starting scratching, crying, unable to sleep, and miserable. Went to the ER twice, first treated with antibiotic, benadryl, and steroid. Second time, antibiotic, discontinued and steroid shot given, and told to continue with Benadryl. ER physician told me the reaction was due to MMR vaccine. I made a follow up appointment with Dr. on 4/19. All of this happening between 4/14/2011 to 4/17/2011.
Age: 1.29
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash generalised, Vaccination site rash
Clinical narrative: Son had a fever from 4/14 to 4/16, along with a rash forming on both vaccination sites on thigh. Afterwards forming small rash and bumps all over body from head to bottom of his feet and starting scratching, crying, unable to sleep, and miserable. Went to the ER twice, first treated with antibiotic, benadryl, and steroid. Second time, antibiotic, discontinued and steroid shot given, and told to continue with Benadryl. ER physician told me the reaction was due to MMR vaccine. I made a follow up appointment with Dr. on 4/19. All of this happening between 4/14/2011 to 4/17/2011.
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, DTAPHEPBIP, HIBV, PNC13
Symptoms: Cyanosis, Pallor, Pyrexia, Vomiting
Clinical narrative: This is a spontaneous report from a contactable nurse. A 2-month-old male patient received a dose of PREVNAR 13 intramuscularly on the right thigh at 12:00 noon on 09Feb2011 along with a dose of PEDIARIX and a dose of PEDVAX-HIB. The patient had no relevant medical history or relevant concomitant medications. On 09Feb2011, the patient developed a fever and vomiting and turned blue. The patient was sent to the emergency room. Therapeutic measures taken as a result of the events included treatment with TYLENOL and ZOFRAN. Relevant lab data included blood work on 09Feb2011 (results unknown). The patient recovered from the events at the time of this report. Based on the information provided in the case, this individual report would not seem to modify the benefit/risk profile of PREVENAR 13.
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, DTAPHEPBIP, HIBV, PNC13
Symptoms: Blood test, Cyanosis, Pyrexia, Vomiting
Clinical narrative: This is a spontaneous report from a contactable nurse. A 2-month-old male patient received a dose of PREVNAR 13 intramuscularly on the right thigh at 12:00 noon on 09Feb2011 along with a dose of PEDIARIX and a dose of PEDVAX-HIB. The patient had no relevant medical history or relevant concomitant medications. On 09Feb2011, the patient developed a fever and vomiting and turned blue. The patient was sent to the emergency room. Therapeutic measures taken as a result of the events included treatment with TYLENOL and ZOFRAN. Relevant lab data included blood work on 09Feb2011 (results unknown). The patient recovered from the events at the time of this report. Based on the information provided in the case, this individual report would not seem to modify the benefit/risk profile of PREVENAR 13.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Deafness unilateral
Clinical narrative: Information has been received from a Doctor of pharmacy concerning an 81 year old female patient with no known drug allergies who on 07-APR-2011, was vaccinated subcutaneously in left arm with 0.65 mL of ZOSTAVAX (Merck) (Lot# 669590/1507Z, expiration: 02-FEB-2012). Concomitant therapy included LEVOXYL and DIOVAN. The pharmacist reported that on 08-APR-2011 the patient experienced complete hearing loss in her left ear after administration of ZOSTAVAX (Merck). The patient sought unspecified medical attention. No laboratories were performed. No treatment was given for this adverse event. At the time of reporting the patient had not recovered. The pharmacist considered the complete hearing loss in patient's left ear to be disabling. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Cold sweat, Convulsion, Musculoskeletal stiffness, Syncope, VIIth nerve paralysis
Clinical narrative: Information has been received from a medical assistant concerning a 12 year old female patient with no pertinent medical history and no drug reactions or allergies reported, who on 25-JUN-2010 was vaccinated with her first dose of GARDASIL (Lot #: 666118/1539Y, Exp: March-2013), 0.5ml, intramuscularly.  Concomitant medications administered on 25-JUN-2010 included: ADACEL, MENACTRA.  Secondary suspect include VARIVAX (Merck) (lot # not reported).  The medical assistant reported that after receiving the GARDASIL, the patient had a "fainting spell" where the patient turned stiff, convulsed and experienced facial paralysis which lasted for 5 seconds.  Medical assistant reported that the entire event lasted 7 seconds, and the patient's vital signs were stable.  Medical assistant reported that the patient "was a little clammy" following the "fainting spell" and stayed in the physician's office for 30 minutes after the events, so that she could be observed, and she completely recovered.  On 27-AUG-2010, the patient received the second dose of GARDASIL (Lot#: 666929/0331Z, Exp: 05-APR-2013), 0.5 ml, intramuscularly, and fainted for 3 seconds, but the patient had no facial paralysis.  Medical assistant reported that the patient experienced "a little stiffness", but she did not experience convulsions following the second dose of GARDASIL.  Unspecified treatment was given for the events.  No laboratory diagnostic studies were performed.  Medical assistant reported that the patient completely recovered from this experience.  On 06-APR-2011, the patient received her third dose of GARDASIL (Lot #: 668229/1569Z) (dose and route not reported), with no other vaccines and with no problems.  Upon internal review convulsion and facial paralysis were considered to be other important medical events.  Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Vaccine positive rechallenge
Clinical narrative: Information has been received from a medical assistant concerning a 12 year old female patient with no pertinent medical history and no drug reactions or allergies reported, who on 25-JUN-2010 was vaccinated with her first dose of GARDASIL (Lot #: 666118/1539Y, Exp: March-2013), 0.5ml, intramuscularly.  Concomitant medications administered on 25-JUN-2010 included: ADACEL, MENACTRA.  Secondary suspect include VARIVAX (Merck) (lot # not reported).  The medical assistant reported that after receiving the GARDASIL, the patient had a "fainting spell" where the patient turned stiff, convulsed and experienced facial paralysis which lasted for 5 seconds.  Medical assistant reported that the entire event lasted 7 seconds, and the patient's vital signs were stable.  Medical assistant reported that the patient "was a little clammy" following the "fainting spell" and stayed in the physician's office for 30 minutes after the events, so that she could be observed, and she completely recovered.  On 27-AUG-2010, the patient received the second dose of GARDASIL (Lot#: 666929/0331Z, Exp: 05-APR-2013), 0.5 ml, intramuscularly, and fainted for 3 seconds, but the patient had no facial paralysis.  Medical assistant reported that the patient experienced "a little stiffness", but she did not experience convulsions following the second dose of GARDASIL.  Unspecified treatment was given for the events.  No laboratory diagnostic studies were performed.  Medical assistant reported that the patient completely recovered from this experience.  On 06-APR-2011, the patient received her third dose of GARDASIL (Lot #: 668229/1569Z) (dose and route not reported), with no other vaccines and with no problems.  Upon internal review convulsion and facial paralysis were considered to be other important medical events.  Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: pain and swelling at injection site without infection for 3 weeks
Age: 64.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Herpes zoster, Pain, Rash vesicular
Clinical narrative: Client reported pain on right trunk.  Vaccine administered 10 days previous Sub Q, in Right Arm.  4/14/2011 pt went to see PCP due to formation of rash and fluid filled vesicle on Right shoulder blade.  PCP diagnosed as shingles.  Pt is now undergoing treatment.
Age: 1.0
Sex: M
Vaccine: DTAPIPVHIB, HEPA, MMR, PNC13, VARCEL
Symptoms: Coronary artery dilatation, Echocardiogram abnormal, Kawasaki's disease
Clinical narrative: Atypical Kawasaki Disease
Age: 0.9
Sex: F
Vaccine: IPV
Symptoms: Injection site rash, Rash
Clinical narrative: Rash on forehead. Rash on arms & legs.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Hypersensitivity, Injection site erythema, Injection site induration, Injection site pruritus, Injection site warmth
Clinical narrative: Left arm became red, hot, itchy & hard to touch 2 days after vaccinations. Allergic reaction was diagnosed, patient treated with oral BENADRYL which lead to resolution of symptoms.
Age: 0.5
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13
Symptoms: Dyspnoea, Rash, Swelling face, Urticaria
Clinical narrative: 2 hours after receiving vaccines, patient developed hives, rash, facial swelling & difficulty breathing was taken to ER, treated with BENADRYL & released.
Age: 1.13
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Urticaria
Clinical narrative: Mother reported that her son developed hives. She states he had them the next morning after receiving his immunizations. She states the hives come and go and he had a total of 4 at one time. The baby has no other symptoms.
Age: 46.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Dysstasia, Migraine, Muscle spasms, Pyrexia
Clinical narrative: Patient complains of fever of 100 degrees, migraine headache, chills, total body muscle spasms, & trouble standing. Symptoms started 3-30-11 and resolved by 4-2-2011. No treatment.
Age: 18.0
Sex: M
Vaccine: MMR, MNQ, TDAP, VARCEL
Symptoms: Hunger, Hypotonia, Posture abnormal, Somnolence, Tremor
Clinical narrative: Pt became limp after receiving 4 vaccines. Became limp, slumped down in chair & body began trembling. Called for help. Attempted to stop pt from sliding out of chair. Pt regained composure, reports he is fine, he felt med. go through his body & got sleepy. Help arrived, father arrived. Both deny hx of seizures. Pt denies any other help (referred to E.R.), states he is hungry, & left with father. Received VIS with instructions.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Gastrointestinal surgery, Intestinal resection, Intussusception, Lethargy, Pathology test
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Vitello-intestinal duct remnant, Vomiting
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Abdominal X-ray, Abdominal distension, Blood glucose increased, Blood potassium increased, Culture urine negative
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Dermatitis diaper, Diarrhoea, Haematochezia, Intestinal dilatation, Intestinal resection
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Intussusception, Lethargy, Leukocytosis, Lymphocyte count normal, Mass excision
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Neutrophil percentage increased, Pyrexia, Skin haemorrhage, Skin lesion, Small intestinal obstruction
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Ultrasound abdomen abnormal, Urinary system X-ray, Vitello-intestinal duct remnant, Vomiting, White blood cell count increased
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: X-ray abnormal
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Dermatitis diaper, Diarrhoea, Haematochezia, Haemorrhage, Intestinal dilatation
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Intussusception, Lethargy, Leukocytosis, Lymphocyte count increased, Mass
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Mass excision, Neutrophil count increased, Skin lesion, Small intestinal obstruction, Ultrasound abdomen abnormal
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5, DTAPH, PNC13, RV5, DTAPH, PNC13, RV5
Symptoms: Urinary system X-ray, Vitello-intestinal duct remnant, White blood cell count increased, X-ray abnormal
Clinical narrative: Pt. received 4 month vaccines on 1-31-11. Developed bilious emesis, lethargy on 2-1-11 and was found to have an intussusception and Meckels diverticulum. Mass was resected and reduced successfully.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Nausea, Pyrexia, Somnolence
Clinical narrative: Fever, nausea, drowsiness, red swollen area around injection site with "leather-like" appearance.
Age: 23.0
Sex: F
Vaccine: DTAP
Symptoms: Abdominal discomfort, Abdominal pain upper, Activities of daily living impaired, Asthenia, Balance disorder
Clinical narrative: 4/14/11 8PM: Discomfort in stomach. 4/15/2011 2:30 AM: I threw up (violently). I had trouble sleeping before and after I threw up. I was hoarse and had trouble breathing by 7 AM. I was freezing in sweats and covered in three blankets. I had a severe, pounding headache all day. My arm was sore and swollen from right after the vaccine administration to 4/17/11. My stomach hurt all day (clenching). I continued to be nauseous. I was pale and lost my balance if I stood up for even one or two minutes. I felt dizzy, light-headed, and weak. I read the "What You Need to Know" paper about the Tdap Vaccine, and I realized I was having a moderate to severe reaction to the vaccine. I took my temperature and it was 101.1 degrees Farenheit. I no longer felt freezing, and I wore only sweats and a blanket.  I missed work for the day because I could hardly move. I had no energy; my whole body ached.  4/16/2011: Slightly queasy with dull headache on and off throughout the day. No appetite. I made myself munch on toast, eat an egg, some instant oatmeal, and a slice of bacon throughout the day.
Age: 23.0
Sex: F
Vaccine: DTAP
Symptoms: Decreased appetite, Dizziness, Dysphonia, Dyspnoea, Feeling cold
Clinical narrative: 4/14/11 8PM: Discomfort in stomach. 4/15/2011 2:30 AM: I threw up (violently). I had trouble sleeping before and after I threw up. I was hoarse and had trouble breathing by 7 AM. I was freezing in sweats and covered in three blankets. I had a severe, pounding headache all day. My arm was sore and swollen from right after the vaccine administration to 4/17/11. My stomach hurt all day (clenching). I continued to be nauseous. I was pale and lost my balance if I stood up for even one or two minutes. I felt dizzy, light-headed, and weak. I read the "What You Need to Know" paper about the Tdap Vaccine, and I realized I was having a moderate to severe reaction to the vaccine. I took my temperature and it was 101.1 degrees Farenheit. I no longer felt freezing, and I wore only sweats and a blanket.  I missed work for the day because I could hardly move. I had no energy; my whole body ached.  4/16/2011: Slightly queasy with dull headache on and off throughout the day. No appetite. I made myself munch on toast, eat an egg, some instant oatmeal, and a slice of bacon throughout the day.
Age: 23.0
Sex: F
Vaccine: DTAP
Symptoms: Headache, Insomnia, Mobility decreased, Nausea, Oedema peripheral
Clinical narrative: 4/14/11 8PM: Discomfort in stomach. 4/15/2011 2:30 AM: I threw up (violently). I had trouble sleeping before and after I threw up. I was hoarse and had trouble breathing by 7 AM. I was freezing in sweats and covered in three blankets. I had a severe, pounding headache all day. My arm was sore and swollen from right after the vaccine administration to 4/17/11. My stomach hurt all day (clenching). I continued to be nauseous. I was pale and lost my balance if I stood up for even one or two minutes. I felt dizzy, light-headed, and weak. I read the "What You Need to Know" paper about the Tdap Vaccine, and I realized I was having a moderate to severe reaction to the vaccine. I took my temperature and it was 101.1 degrees Farenheit. I no longer felt freezing, and I wore only sweats and a blanket.  I missed work for the day because I could hardly move. I had no energy; my whole body ached.  4/16/2011: Slightly queasy with dull headache on and off throughout the day. No appetite. I made myself munch on toast, eat an egg, some instant oatmeal, and a slice of bacon throughout the day.
Age: 23.0
Sex: F
Vaccine: DTAP
Symptoms: Pain, Pain in extremity, Pallor, Vomiting
Clinical narrative: 4/14/11 8PM: Discomfort in stomach. 4/15/2011 2:30 AM: I threw up (violently). I had trouble sleeping before and after I threw up. I was hoarse and had trouble breathing by 7 AM. I was freezing in sweats and covered in three blankets. I had a severe, pounding headache all day. My arm was sore and swollen from right after the vaccine administration to 4/17/11. My stomach hurt all day (clenching). I continued to be nauseous. I was pale and lost my balance if I stood up for even one or two minutes. I felt dizzy, light-headed, and weak. I read the "What You Need to Know" paper about the Tdap Vaccine, and I realized I was having a moderate to severe reaction to the vaccine. I took my temperature and it was 101.1 degrees Farenheit. I no longer felt freezing, and I wore only sweats and a blanket.  I missed work for the day because I could hardly move. I had no energy; my whole body ached.  4/16/2011: Slightly queasy with dull headache on and off throughout the day. No appetite. I made myself munch on toast, eat an egg, some instant oatmeal, and a slice of bacon throughout the day.
Age: 20.0
Sex: F
Vaccine: HEP
Symptoms: Blood test, Dizziness, Drug exposure during pregnancy, Headache, Heart rate increased
Clinical narrative: headache, dizziness, fast heartbeat/paleness
Age: 20.0
Sex: F
Vaccine: HEP
Symptoms: Laboratory test, Pallor
Clinical narrative: headache, dizziness, fast heartbeat/paleness
Age: 1.26
Sex: F
Vaccine: DTAPIPVHIB, PNC13
Symptoms: Pyrexia, Urine analysis normal
Clinical narrative: Patient developed fever of 105.5 Temporally.
Age: 62.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Back pain, Monoparesis, Neck pain
Clinical narrative: I lost the ability to use both my legs the evening the shot was given. I lost the ability to use my legs for part of an hour. Less than one hour. (Between 9 and 10 PM, 3/11/11). Week of 4/11/11 - unusual back pain, lower with hip & neck/for 2 weeks after shot, health compromised.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Vaccination site cellulitis, Vaccination site pain, Vaccination site swelling
Clinical narrative: Dtap administered in Right Deltoid IM on 4/15/2011, patient presented with redness, swelling, and pain at vaccine site on 4/17/11.  Treated with Antibiotic due to dx of cellultis.
Age: 0.22
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Infection, Pyrexia
Clinical narrative: Fever most likely due to infection - less likely due to immunization - seen at ER - possible infection per ER.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Child was immunized on 4/4/11 Mom noted increased redness/swelling, warmth to area (L) deltoid 4/5/11. Today area circular 6 1/2 cm., red, warm, slight tender to touch.
Age: 0.26
Sex: F
Vaccine: HIBV
Symptoms: Incorrect dose administered
Clinical narrative: An additional dose of HIB (Haemophilus influenza) vaccine was given in error on 01-21-2011. Error not known/discovered until 4-11-2011.
Age: 19.0
Sex: F
Vaccine: MMR
Symptoms: Dizziness, Dyspnoea, Nausea, Sensation of foreign body
Clinical narrative: Lump in throat, short of breath, dizzy, lightheaded, nausea.
Age: 39.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Rash papular
Clinical narrative: Red papular rash (L) chest, trunk & upper back. Afebrile.
Age: 0.51
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: No adverse event observed or reported.
Age: 19.0
Sex: F
Vaccine: VARCEL
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: No treatment/no reaction. Varicella given too soon after MMR. Time occurred 3/22/11 1344.
Age: 59.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash pruritic, Rash vesicular, Scab
Clinical narrative: 4/8/11 Pt reported  having 20 -30 vesicular "pox" on trunk & scalp. Felt well otherwise. Rash itchy, "pox" opened, crusted & scabbed over 5 - 7 days. Onset was 4/6/11.
Age: 31.0
Sex: F
Vaccine: PPV
Symptoms: Dyspnoea, Erythema, Mobility decreased, Oedema peripheral, Skin warm
Clinical narrative: Pt. states went to ER on 2-11-11 night of injection, with SOB arm swollen & red & hot to touch. Arm swelling & even under her armpit. Had limited mobility of that arm & while at ER started breaking out in welts. ER gave her IV meds & sent her home on steroids. - This is all per pt. We also received a Triage call report from where pt had called in to them.
Age: 31.0
Sex: F
Vaccine: PPV
Symptoms: Urticaria
Clinical narrative: Pt. states went to ER on 2-11-11 night of injection, with SOB arm swollen & red & hot to touch. Arm swelling & even under her armpit. Had limited mobility of that arm & while at ER started breaking out in welts. ER gave her IV meds & sent her home on steroids. - This is all per pt. We also received a Triage call report from where pt had called in to them.
Age: 22.0
Sex: F
Vaccine: TDAP
Symptoms: Hypoaesthesia, Injection site pain
Clinical narrative: Client in clinic for Family Planning - vaccines offered & client agreed to update tetanus with Tdap/client's Mo. phone 03/21/11 about 1pm reporting it "hurt at the time and conts to hurt from [injection site] to below - elbow to fingertips numb. Note: never came in for PPD reading 03/17 appt. - PC resched. for 03/18 - no show.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pain
Clinical narrative: Recieved 4 shots on 4/12/11, on 4/13/11 call rcieved that right arm was red and sore.  On 4/16/11 patient seen in office and diagnosed with Right arm cellulitis at the Dtap site.  Treated with antibiotic.
Age: 1.27
Sex: F
Vaccine: DTAP, HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Blister, Pyrexia, Rash generalised
Clinical narrative: Pt received vaccines on 4/6/11. On 4/15/11 child noted with fever of 100 degrees & went to 102 that night, also noted that night was a rash all over body, no itching noted, also a blister on chin noted. Child's behavior appeared normal. Parent called clinic this AM 4/18/11 to report above. States has been giving child oatmeal baths. Advised mother to seek medical attention, they called Pedi clinic, advised to wash blister with antibacterial soap, apply NEOSPORIN, cont oatmeal baths, come in if condition worsens. No fever noted today per parent.
Age: 46.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Erythema, Oedema peripheral, Pain
Clinical narrative: Pain, redness, swelling of arm and axilla.
Age: 15.0
Sex: M
Vaccine: HEP, HEPA, HPV4, IPV, MNQ, TDAP
Symptoms: Joint swelling, Rash generalised, Swelling
Clinical narrative: Rash and swelling throughout body. States rash lasted approximately one week. Swelling in ankles still not resolved.
Age: 0.43
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Acidosis, Asthenia, Blood bicarbonate decreased, Crying, Drug screen negative
Clinical narrative: Patient had received immunizations the day prior to the event. She was fine the rest of the day, awakened fine on the day of the event and ate well, but, after a (usual) 1.5 hour nap, from which she awakened crying, her mother found her to be excessively floppy, and, although she ate a bottle well, she remained floppy, unable to hold her head up, with decreased tone and strength. She vomited once. No cough, diarrhea, fever. Examination in clinic about one hour later revealed slight weakness, only, slight head lag in prone. She was hospitalized overnight, and did well.
Age: 0.43
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Full blood count normal, Head lag, Hypotonia, Metabolic function test, Posture abnormal
Clinical narrative: Patient had received immunizations the day prior to the event. She was fine the rest of the day, awakened fine on the day of the event and ate well, but, after a (usual) 1.5 hour nap, from which she awakened crying, her mother found her to be excessively floppy, and, although she ate a bottle well, she remained floppy, unable to hold her head up, with decreased tone and strength. She vomited once. No cough, diarrhea, fever. Examination in clinic about one hour later revealed slight weakness, only, slight head lag in prone. She was hospitalized overnight, and did well.
Age: 0.43
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Urine analysis normal, Vomiting
Clinical narrative: Patient had received immunizations the day prior to the event. She was fine the rest of the day, awakened fine on the day of the event and ate well, but, after a (usual) 1.5 hour nap, from which she awakened crying, her mother found her to be excessively floppy, and, although she ate a bottle well, she remained floppy, unable to hold her head up, with decreased tone and strength. She vomited once. No cough, diarrhea, fever. Examination in clinic about one hour later revealed slight weakness, only, slight head lag in prone. She was hospitalized overnight, and did well.
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Pyrexia, Tenderness
Clinical narrative: Fever, tenderness
Age: 2.0
Sex: M
Vaccine: IPV
Symptoms: Diarrhoea, Irritability, Pyrexia
Clinical narrative: irritability, fever, diarrhea
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Rash generalised
Clinical narrative: PT'S FATHER STATES APPROXIMATELY ONE HOUR AFTER RECEIVING GARDASIL SHE BROKE OUT IN A RASH ALL OVER HER BODY. INSTRUCTED TO TAKE BENADRYL. F/U IN ER IF S/S ANAPHYLACTIC SHOCK.
Age: 65.0
Sex: M
Vaccine: PPV, TDAP, TYP, YF
Symptoms: Asthenia, Back pain, Chills, Fatigue, Headache
Clinical narrative: On 04/13/11 was outside and c/o chills and Headache. Took shower at 8:30 PM and temp. at 9:30 PM had 103 degree fever and went to bed. At 5:30 AM on 04/14/11 temp. 101 derees and took 2 Aleve tablets. Cont to c/o headache, fatigue and weakness throughout the day. Seen by MD on 04/15/11. MD stated exam showed no signs of an infection or other illness not related to vaccine. Recommended Pt increase amounts of Naprosyn. On 04/16/11 c/o swelling at upper half of body accompanied by pain. Severe pain at sternum and upper back between shoulder blades. 04/17/11 pain began to subside but continued to have some fatigue until this AM of 04/18/11.
Age: 65.0
Sex: M
Vaccine: PPV, TDAP, TYP, YF
Symptoms: Musculoskeletal pain, Non-cardiac chest pain, Pyrexia, Swelling
Clinical narrative: On 04/13/11 was outside and c/o chills and Headache. Took shower at 8:30 PM and temp. at 9:30 PM had 103 degree fever and went to bed. At 5:30 AM on 04/14/11 temp. 101 derees and took 2 Aleve tablets. Cont to c/o headache, fatigue and weakness throughout the day. Seen by MD on 04/15/11. MD stated exam showed no signs of an infection or other illness not related to vaccine. Recommended Pt increase amounts of Naprosyn. On 04/16/11 c/o swelling at upper half of body accompanied by pain. Severe pain at sternum and upper back between shoulder blades. 04/17/11 pain began to subside but continued to have some fatigue until this AM of 04/18/11.
Age: 0.39
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Body temperature increased, Crying
Clinical narrative: Mother reports after last immunizations infant having elevated temp., 101 to 102 degrees, high pitched cry, with periods of inconsolable crying after visiting with ARNP was told to give acetaminophen alternating with ibuprofen.
Age: 58.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Pain and erythema at injection site
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Blepharospasm, Hypoaesthesia, Tremor
Clinical narrative: Patient described to me "Within a 1/2 hour I started experiencing symptoms of temors, numb left fingers, eye twitching... Proceeded to be examined by neurologist along with other physicians the past several months.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HIBV, MMR, PNC13, VARCEL
Symptoms: Blood sodium decreased, CSF culture negative, CSF glucose decreased, CSF lymphocyte count, CSF protein normal
Clinical narrative: Patient had acute onset of headache that progressed over the next 2 days and was described as frontal, throbbing, and continuous.  He had a tactile temperature associated with the headache, but no vomiting or diarrhea. Patient went to ER on 04/15/2011 and then another ER on 4/16/2011, transferred to inpatient pediatrics floor 04/16/2011.  Still hospitalized as of 4/18/2011 for workup and treatment, patient appears clinically better at times, but at others has possible meningitic findings.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HIBV, MMR, PNC13, VARCEL
Symptoms: CSF white blood cell count, CSF white blood cell count increased, Carbon dioxide decreased, Haematocrit normal, Haemoglobin normal
Clinical narrative: Patient had acute onset of headache that progressed over the next 2 days and was described as frontal, throbbing, and continuous.  He had a tactile temperature associated with the headache, but no vomiting or diarrhea. Patient went to ER on 04/15/2011 and then another ER on 4/16/2011, transferred to inpatient pediatrics floor 04/16/2011.  Still hospitalized as of 4/18/2011 for workup and treatment, patient appears clinically better at times, but at others has possible meningitic findings.